| A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis (NCT04342715) | University of York | 2022-05-22 |
| Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure (NCT05426577) | Foundation for Innovative New Diagnostics, Switzerland | 2021-09-01 |
| Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects (NCT03929016) | Drugs for Neglected Diseases | 2019-04-04 |
| LAMP Assay for the Diagnosis of Visceral Leishmaniasis (NCT04003532) | Prof. Dawit Wolday | 2018-10-01 |
| Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition (NCT03636659) | Aurobindo Pharma Ltd | 2018-05-02 |
| Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa (NCT03129646) | Drugs for Neglected Diseases | 2018-01-24 |
| Improved Case Detection and Vector Control for Visceral Leishmaniasis (NCT03269006) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2016-01-01 |
| Asymptomatic Leishmania Infection in HIV Patients (NCT02839603) | Institute of Tropical Medicine, Belgium | 2015-09-01 |
| Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa (NCT02431143) | Drugs for Neglected Diseases | 2015-05-01 |
| Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (NCT02011958) | Drugs for Neglected Diseases | 2014-07-01 |
| Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis (NCT01566552) | Banaras Hindu University | 2014-06-01 |
| Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (NCT02071758) | Access to Advanced Health Institute (AAHI) | 2014-04-01 |
| Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan (NCT01980199) | Drugs for Neglected Diseases | 2013-11-01 |
| Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (NCT01766830) | University Hospital, Geneva | 2013-01-01 |
| Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (NCT01310738) | University of Brasilia | 2011-02-01 |
| An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh (NCT01328457) | PATH | 2011-01-01 |
| Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh (NCT01122771) | Drugs for Neglected Diseases | 2010-05-01 |
| Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine (NCT01138956) | Hospital Universitário Professor Edgard Santos | 2010-04-01 |
| Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia (NCT02148822) | Instituto de Salud Carlos III | 2009-12-01 |
| A Community Trial for Visceral Leishmaniasis (VL) (NCT01069198) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2009-10-01 |
| Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL (NCT00832208) | Drugs for Neglected Diseases | 2009-04-01 |
| Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis (NCT00696969) | Drugs for Neglected Diseases | 2008-06-01 |
| An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis (NCT00629031) | Banaras Hindu University | 2008-02-01 |
| Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis (NCT00604955) | PATH | 2007-10-01 |
| Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar (NCT00371995) | Banaras Hindu University | 2007-10-01 |
| Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children (NCT01032187) | University of Brasilia | 2007-10-01 |
| A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh (NCT01240473) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2007-04-01 |
| Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India (NCT00486382) | Access to Advanced Health Institute (AAHI) | 2007-04-01 |
| A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar (NCT00497601) | Banaras Hindu University | 2007-02-01 |
| Combination Chemotherapy for the Treatment of Indian Kala-Azar (NCT00370825) | Banaras Hindu University | 2006-09-01 |
| Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar (NCT00318721) | London School of Hygiene and Tropical Medicine | 2006-06-01 |
| Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis (NCT00255567) | Drugs for Neglected Diseases | 2004-11-01 |
| Immunogenetics of Visceral Leishmaniasis (NCT00342823) | National Human Genome Research Institute (NHGRI) | 2003-10-20 |
| Amphotericin B Treatment in Visceral Leishmaniasis (NCT00310505) | Banaras Hindu University | 2003-01-01 |